Spots Global Cancer Trial Database for A Study of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia
Official Title: A Multicenter, Open Clinical Trial to Evaluate the Safety and Efficacy of ICP-022 in the Treatment of Recurrent or Refractory Waldenstrom Macroglobulinemia (WM)
Study ID: NCT04440059
Interventions
Study Description
Brief Summary: The phase II clinical study is to investigate the safety, tolerability, efficacy and pharmacokinetics of ICP-022. Safety, tolerability evaluation, and anti-tumor effects of ICP-022 in Chinese patients with R/R WM will be evaluated in approximately 44 subjects. Pharmacokinetics of ICP-022 will be evaluated in approximately 20 subjects.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
The First Affiliated Hospital of University of Science and Technology of China (Anhui Provincial Hospital), Hefei, Anhui, China
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China
West China hospital of sichuan university, Sichuan, Chengdu, China
Union Hospital affiliated to Fujian Medical University, Fuzhou, Fujian, China
The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
Henan Cancer Hospital, Zhengzhou, Henan, China
Henan Provincial Peoples's Hospital, Zhengzhou, Henan, China
Tongji Hospital affiliated to Huazhong University of Science and Technology, Wuhan, Hubei, China
Jiangsu Province Hospital, Nanjing, Jiangsu, China
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Shengjing Hospital of China Medical University, Shenyang, Liaoning, China
Ruijin Hospital affiliated to Shanghai Jiao Tong University, Shanghai, Shanghai, China
Hospital of Hematology, Chinese Academy of Medical Sciences, Tianjin, Tianjin, China
Union Hospital affiliated to Huazhong University of Science and Technology, Hubei, Wuhan, China
The First Affiliated Hospital of Zhejiang University Medical College, Hangzhou, Zhejiang, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
